WO2009109645A2 - Implant osseux porteur de charge comportant un élastomère thermoplastique - Google Patents

Implant osseux porteur de charge comportant un élastomère thermoplastique Download PDF

Info

Publication number
WO2009109645A2
WO2009109645A2 PCT/EP2009/052643 EP2009052643W WO2009109645A2 WO 2009109645 A2 WO2009109645 A2 WO 2009109645A2 EP 2009052643 W EP2009052643 W EP 2009052643W WO 2009109645 A2 WO2009109645 A2 WO 2009109645A2
Authority
WO
WIPO (PCT)
Prior art keywords
load
bone
hard
tpe
polyester
Prior art date
Application number
PCT/EP2009/052643
Other languages
English (en)
Other versions
WO2009109645A3 (fr
Inventor
Darren Donald Obrigkeit
Leo Smit
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of WO2009109645A2 publication Critical patent/WO2009109645A2/fr
Publication of WO2009109645A3 publication Critical patent/WO2009109645A3/fr
Priority to CN2010800106379A priority Critical patent/CN102341131A/zh
Priority to JP2011552468A priority patent/JP2012519516A/ja
Priority to PCT/EP2010/052854 priority patent/WO2010100267A1/fr
Priority to US13/203,131 priority patent/US9452061B2/en
Priority to EP10706668A priority patent/EP2403548A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Definitions

  • the invention pertains to a load-bearing bone implant suitable for permanent implantation.
  • the invention also pertains to the use of the implant in support of bone growth, such as in bone healing and particularly in joint fusion (arthrodesis).
  • the invention further pertains to bone-growth procedures, such as procedures for bone healing and particularly for arthrodesis.
  • Implants generally has a broad meaning, referring to any foreign object that is placed in a living human or animal body.
  • Implants can be temporary, such as implants in the form of pharmaceutical dosage forms for the controlled release of drugs, or implants that are bioabsorbable and are therefore used for a temporary function.
  • Implants can be permanent, such as a metal pin to support a broken leg.
  • permanent will be readily understood as referring to anything that is intended to remain indefinitely in the body. This does not mean that the implant could not be removed, e.g. surgically, or could not accidentally disappear.
  • the invention relates to such implants as are suitable for permanent implantation, hence to biostable implants rather than to implants that are bio-absorbable or biodegradable.
  • a biostable implant will remain as is, i.e. once a biologically acceptable implant is introduced into the body of a living human or animal, it is traceable which material is in fact implanted. In the case of an implant that degrades in the body, and/or is absorbed by the body, it will be generally unpredictable which degradation, conversion or metabolic materials will eventually end up in the body. From a viewpoint of controlling the health of the subject receiving the implant, this is undesirable and represents additional clinical risk. Therefore use of resorbable implants are typically restricted to applications where this added risk is balanced by a significant long-term clinical benefit.
  • a permanent implant will also be capable of indefinitely contributing to load-bearing.
  • the term "bone implant” generally indicates that the implant is suitable for use related to bone. This can be in, at or around bone, in lieu of bone, near bone or adjacent to bone, etc.
  • the invention relates to such bone implants as are load- bearing, i.e. adapted to be capable of wholly or partially assuming the load-bearing function of bone, and doing so permanently or temporarily.
  • implants many of which exist, that are used to preserve joint mobility.
  • the latter refers particularly to artificial spinal disks and other forms of arthroplasty joint spacers (e.g. hip, knee) as well as implants for extremities.
  • bone implants and other mobility-preserving implants are not bone implants according to the invention.
  • load-bearing bone implants suitable for permanent implantation include a wide variety of implants, e.g. orthopaedic implants such as pins to support healing broken bones in legs, arms, wrists and the like, but also cervical cages that are used in the arthrodesis of cervical vertebrae, or spacers used in between dissected bones to support their rejoining, and many other implants.
  • orthopaedic implants such as pins to support healing broken bones in legs, arms, wrists and the like
  • cervical cages that are used in the arthrodesis of cervical vertebrae, or spacers used in between dissected bones to support their rejoining
  • many other implants With reference to the use of these implants in e.g. bone-healing, the implants will be load- bearing at least until the bone has healed and will itself be capable of bearing load again. In many constructions for such implant-supported bone-healing, the implant will remain load-bearing itself as well, e.g. as an integral part of the healed bone. Background references in this respect are Clinical
  • the load-bearing nature of the implant may be temporary.
  • two adjacent joints e.g. vertebrae
  • the entire construct of implant (cage) and bone will be load-bearing.
  • Typical , conventional materials for load-bearing, permanent, bone implants are regular orthopaedic implant materials (e.g. Co-Cr implant alloys, stainless steel or titanium) or - fiber reinforced - high-tensile strength polymeric materials (e.g. polyetherether ketone - PEEK or ultra high molecular weight polyethylene - UHMWPE).
  • regular orthopaedic implant materials e.g. Co-Cr implant alloys, stainless steel or titanium
  • - fiber reinforced - high-tensile strength polymeric materials e.g. polyetherether ketone - PEEK or ultra high molecular weight polyethylene - UHMWPE.
  • Load-bearing, permanent bone implants are not without problems, particularly due to the fact that these implants are frequently used in a situation that itself is not stable.
  • an implant used as a support in bone healing may have a much more prominent load-bearing function until the bone has healed, than thereafter.
  • the implant while the implant permanently stays in or at the healed bone, it may serve to remove normal stress from the healed bone.
  • This so-called stress shielding to which bone implants made of more conventional materials are prone, may result in osteopenia comparable to situations in which the bone is deprived of its normal stress (e.g. such as a leg not used because of injury will become thinner than the other, fully used leg).
  • Another problem relates to endplate stability, particularly to subsidence of spacers, such as cervical and lumbar cages, used in arthrodesis of vertebrae. As described by Bartels et al. in Neurosurgery, Volume 58, Number 3, March 2006, pages 502-508, these cages can sink into the vertebral body. A further problem relates to expulsion and/or migration of the implants.
  • load-bearing bone implant suitable for permanent implantation, that will reduce the chance of such subsidence, migration or expulsion.
  • Another problem associated with conventional load-bearing bone implants suitable for permanent implantation is that bone growth can be inhibited as a result of the presence of the implant. This is believed to be caused by such factors as wear, resulting in debris, or the nature of the material (e.g. silicone osteolysis in the case of silicone implants).
  • a bone implant suitable for permanent implantation, comprising a thermoplastic elastomer (TPE) comprising a hard phase and soft phase, wherein the hard phase comprises a polymer chosen from the group consisting of polyester, polyamide, polystyrene, polyacrylate and polyolefin and the soft phase comprises a polymer chosen from the group consisting of polyether, polyester, polyacrylate, polyolefin and polysiloxane.
  • TPE thermoplastic elastomer
  • the material selected has the ability to provide stiffness at or below that of the surrounding bone. This produces an implant which will retain its shape over time and allow the surrounding bone to regrow while preventing stress shielding and/or inhibition of bone growth associated with implants which are too stiff.
  • the selection of an elastomer results in a more natural stress behaviour of the resulting implant-provided bone, i.e. different from a more rigid conventional implant.
  • the elastomer better addresses stress shielding, absorbing stress to much more the same extent as bone does.
  • elastomer has sufficient compressive and tensile strength to assume the load- bearing function of bone.
  • the aforementioned polymers such as PEEK or UHMWPE are used. These have a very high tensile strength, but a low Young's modulus (tensile modulus of elasticity).
  • the other regularly used materials suffer from a similar drawback.
  • the TPE's according to the invention will preferably have a tensile strength of from 10-50 MPa, and more preferably within the above-mentioned range for TPE (28-50 MPa). Also, the TPE's used according to the invention preferably have a Young's modulus of 0.01-3 GPa (with the upper values (2-3 GPa) preferably achieved through the use of hard fillers), and more preferably within the above-mentioned range for TPE (0.14-2.6 GPa). Most preferably, the TPE's used in the invention are selected to as to combine these properties within the preferred ranges.
  • the invention thus also pertains to the use, in a bone implant suitable for permanent implantation, of a material satisfying the foregoing combination of strength and modulus.
  • the implant according to the invention comprises the aforementioned TPE, and also other elastomeric and/or polymeric materials, the aforementioned ranges will provide the person skilled in the art with guidance on which materials to use.
  • the polymer in the implant is substantially (i.e. more than 50%) a TPE as defined above, and it is more preferred for the polymer of the implant to consist essentially of the TPE.
  • fillers it is well possible, and often preferred, to modify the TPE by rendering it into a composite, e.g. by including fillers.
  • These fillers can be used in a wide variety of percentages, and by virtue of the good flow properties of the TPE's according to the invention, this can be at a level of more than 50%, e.g. up to 60%.
  • Hard fillers are known to the skilled person, e.g. mineral fillers.
  • any ingredients in addition to the TPE will at least be biocompatible, and more preferably of pharmaceutical quality.
  • the implant can be a porous structure containing additives that promote bone growth, e.g. growth factors such as bone morphogenic protein (BMP), transforming growth factor beta and platelet derived growth factor, osteogenic growth factors such as bone-derived growth factor, activin, insulin-like growth factor, basic fibroblast growth factor and combinations thereof.
  • growth factors such as bone morphogenic protein (BMP), transforming growth factor beta and platelet derived growth factor, osteogenic growth factors such as bone-derived growth factor, activin, insulin-like growth factor, basic fibroblast growth factor and combinations thereof.
  • the TPE according to the invention particularly exhibits low creep and low compression set.
  • Compression set testing is used to determine the ability of elastomeric materials to maintain elastic properties after dynamic stress or prolonged compressive stress. The test measures the somewhat permanent deformation of the specimen after it has been exposed to compressive stress for a set time period. This test is particularly useful for applications in which elastomers would be in a constant pressure/release state, as will be the case for a bone implant that is load-bearing.
  • the compression set for TPE's is only about 15-20%.
  • TPE's are e.g. a high resilience to mechanical forces, by virtue of its crystalline (hard block) component.
  • the TPE can easily be processed to provide a variety of designs, by for example injection moulding. This is an important advantage for use in implants intended for living beings, as the exact shape and size of an implant will normally be determined on an individual basis.
  • the shape of the implant according to the invention can easily be adapted during surgery, e.g. to accommodate the patient's anatomy.
  • the TPE also enjoys a good crack growth resistance, high wear resistance, high dimensional stability and high resistance to moisture, such that a compliant durable implant can be made.
  • a bone implant may comprise only one part.
  • the implant may consist of two or more parts of which at least one part is made of the TPE according to the invention.
  • the TPE can be combined with other elastomeric materials of different stiffness and flexibility and/or hard materials, such as metals and higher modulus polymers.
  • Another advantage of using the TPE according to the invention in a bone implant is that the shape of the load-bearing bone implant according to the invention can easily be adapted during surgery to adapt it to the patient's anatomy.
  • the bone implant according to the invention comprises a thermoplastic elastomer comprising a hard phase and a soft phase.
  • the hard phase in the TPE comprises a rigid polymer phase with a melting temperature (Tm) or a glass transition temperature (Tg) higher than 35 0 C.
  • the soft phase in the TPE comprises a flexible, amorphous polymer phase with a Tg lower than 35 0 C, preferably lower than 0 0 C.
  • Tm and Tg were determined on a dry sample.
  • the TPE, used according to the invention comprises, for example, blends of the above-mentioned hard phase polymers with soft phase polymers and block copolymers.
  • the hard and the soft phase can comprise one polymer type, but can also be composed of a mixture of two or more of the above-mentioned polymeric materials.
  • the TPE, used according to the invention is a block- copolymer.
  • the TPE used in the bone implant comprises a thermoplastic elastomer comprising hard blocks and soft blocks, wherein the hard blocks comprise a polymer chosen from the group consisting of polyester, polyamide, polystyrene, polyacrylate and polyolefin and the soft blocks comprise a polymer chosen from the group consisting of polyether, polyester, polyacrylate, polyolefin and polysiloxane.
  • TPE block-copolymers are block-copolyesterester, block-copolyetherester, block-copolycarbonateester, block- copolysiloxaneester, block-copolyesteramide, block-copolymer containing polybutylene terephthalate (PBT) hard blocks and poly(oxytetramethylene) soft blocks, block- copolymer containing polystyrene hard blocks and ethylene butadiene soft blocks (SEBS), polyurethane comprising polybutylene terephthalate (PBT) hard blocks and polycarbamate soft blocks.
  • PBT polybutylene terephthalate
  • SEBS ethylene butadiene soft blocks
  • SEBS ethylene butadiene soft blocks
  • the hard blocks in the thermoplastic elastomer consist of a rigid polymer, as described above, with a Tm or Tg higher than 35 0 C.
  • the different polymers as described above can be used as the hard blocks.
  • a polycarbonate or a polycarbamate is understood to be a polyester.
  • copolymers of esters, amides, styrenes, acrylates and olefins can be used as the hard polymer block as long as the Tm or Tg of the hard polymer block is higher than 35 0 C.
  • the hard block of the TPE is a polyester block. It has been found that, with respect to their use in the load-bearing bone implant according to the invention, in particular TPE's with a polyester hard block have many advantages including low creep, low compression set, high dimensional stability and high resistance to moisture.
  • the hard block consists of repeating units derived from at least one alkylene glycol and at least one aromatic dicarboxylic acid or an ester thereof.
  • the alkylene group generally contains 2-6 carbon atoms, preferably 2-4 carbon atoms.
  • Preferable for use as the alkylene glycol are ethylene glycol, propylene glycol and in particular butylene glycol.
  • Terephthalic acid, 2,6-naphthalenedicarboxylic acid and 4,4'-diphenyldicarboxylic acid are very suitable for use as the aromatic dicarboxylic acid. Combinations of these dicarboxylic acids, and/or other dicarboxylic acids such as isophthalic acid may also be used. Their effect is to influence the crystallisation behaviour, e.g. melting point, of the hard polyester blocks.
  • the hard block is polybutyleneterephthalate.
  • the soft blocks in the thermoplastic elastomer consist of a flexible polymer, as described above, with a Tg lower than 35 0 C. In principle the polymers as described above can be used as the soft blocks.
  • a polycarbonate is understood to be a polyester.
  • the soft block comprises a polyester or a polyether; more preferably an aliphatic polyester or polyether.
  • TPE's comprising polyester, or polyether soft blocks is that aliphatic polyesters, and polyethers feature a high chemical stability.
  • alkylene carbonates and aliphatic polyesthers are preferred as the soft block, which result in thermoplastic elastomers with particularly low moisture sensitivity and favourable adhesive properties.
  • the soft blocks in the TPE are derived from at least one alkylene carbonate and optionally, a polyester made up of repeating units derived from an aliphatic diol and an aliphatic dicarboxylic acid.
  • the alkylene carbonate can be represented by the formula
  • the aliphatic diol units are preferably derived from an alkylenediol containing 2 - 20 C atoms, preferably 3 - 15 C atoms, in the chain and an alkylenedicarboxylic acid containing 2 - 20 C atoms, preferably 4 - 15 C atoms.
  • the soft block comprises a polycarbonate.
  • the TPE comprises a hard block comprising polybutyleneterephthalate and a soft block comprising polycarbonate.
  • this TPE is chain-extended with diisocyanate.
  • block-copolyester esters are for example described in the Handbook of Thermoplastics, ed. O.OIabishi, Chapter 17, Marcel Dekker Inc., New York 1997, ISBN 0-8247-9797-3, Thermoplastic Elastomers, 2nd Ed., Chapter 8, Carl Hanser Verlag (1996), ISBN 1-56990-205-4, and the Encyclopedia of Polymer Science and Engineering, Vol. 12, pp.75-1 17, and the references contained therein.
  • polyethylene oxide is used as the soft block, which has a good biocompatibility and was found to result in osteoconductive (e.g. bone-bonding) surfaces capable of osteointegration.
  • the PEO soft block can, for example, be combined with a PBT hard block. This can also be applied to adjust the implant surface so as to positively affect bone growth, e.g. by incorporating it as a surface layer or film on another polymer (e.g. the unmodified TPE) as a core.
  • the possibilities of using adjusting chemistry to modify surface properties can be viewed as an additional advantage of the TPE's as used in the invention.
  • the ratio of the soft and hard blocks in the TPE used in the load- bearing bone implant according to the invention may generally vary within a wide range but is in particular chosen in view of the desired modulus of the TPE.
  • the desired modulus will depend on the structure and size (e.g. thickness) of the implant and the functionality of the TPE in it. Generally a higher soft block content results in higher flexibility and better toughness.
  • the TPE according to the invention may contain one or more additives such as stabilizers, anti-oxidants, colorants, fillers, binders, fibers, meshes, substances providing radio-opacity, surface active agents, foaming agents, processing aids, plasticizers, biostatic/biocidal agents, and any other known agents which are described in Rubber World Magazine Blue Book, and in Gaether et al., Plastics Additives Handbook, (Hanser 1990).
  • suitable examples of fillers e.g. radio-opaque fillers and bone-mineral based fillers, and binders are described in U.S. Patent Number 6,808,585B2 in columns 8-10 and in U.S. Patent Number 7,044,972B2 in column 4, I.
  • Typical fillers are selected from the group of calcium-based fillers (such as calcium phosphate, hydroxyapatite, tricalcium phosphate, calcium sulfate, demineralized bone, autologous bone, coralline substances), carbon-based fillers (such as carbon fiber, graphite, pyrolytic carbon, diamond), polyketones (such as polyetheretherketone - PEEK, polyaryletherketone - PAEK, and polyetherketoneketone - PEKK), ceramic-based fillers (such as bioceramics , zirconium dioxide, alumina, silicon nitride, zirconia-toughened alumina), glass fillers (such as glass fibers, Bioglass®, bioactive glass ceramics, e.g.
  • calcium-based fillers such as calcium phosphate, hydroxyapatite, tricalcium phosphate, calcium sulfate, demineralized bone, autologous bone, coralline substances
  • carbon-based fillers such as carbon fiber,
  • apatite- wollastonite metallic fillers & fibers (such as titanium and alloys, tantalum, stainless steels, cobalt chrome alloys, gold, silver, platinum), and mixtures thereof.
  • PAEK polyaryletherketone
  • PEI polyetherimide
  • POM polyoxymethylene
  • LCP liquid-crystal polymer
  • PMP polymethyl pen
  • PTE radio-opaque
  • barium and iodine containing compounds or compositions e.g., barium sulfate and barium sulfate for suspension.
  • Suitable commercially available TPE's include Arnitel ® TPE (DSM
  • Arnitel ® E polyether ester, PTMEG
  • Arnitel ® C polycarbonate-ester, PHMC
  • Arnitel ® P polyether ester, polyols, polypropylene and polyethylene
  • Particularly suitable Arnitel ® grades include 55D, EL250, EM400, EM450, EM550, EM630, EL740, PL380, PL381 , PM381 , PL580, PM581 , 3103, 3104, and 3107.
  • thermoplastic block polyesters have been the subject of numerous FDA regulatory approvals. Specifically, Arnitel ® copolyesters have been listed under the Drug Master Files 13260, 13261 , 13263, 13264, 13259, and 13262. Additionally, these compositions have been cleared for use in permanent implants (510(k) K990952, K896946). According to the FDA MAUDE database, adverse events dating back to prior April, 2000 are mild and due to mechanical failure (see catalogue number 8886441433, 447071 , 8886471011 V, and 8886470401 ). The absence of adverse effects due to material confirms the long-term biocompatibility of these compositions.
  • Arnitel ® E grades are in compliance with the code of Federal regulation, issued by the Food and Drug Administration (FDA) 21 CFR 177.2600 (rubber articles for repeated use) in the USA, the so-called FDA approval. Moreover, US Pharmacopoeia approvals were received for the following Arnitel ® grades: EM400, EM450, EM550, EM740, PL580 and 3104 (USP Class Vl), and PL380 and PM381 (USP Class IV). Moreover multiblock poly(aliphatic/aromatic ester) (PED) copolymers as described in M. El Fray and V. Altstadt, Polymer, 44 (2003) pp. 4643-4650 can suitably be used as the TPE according to the invention.
  • FDA Food and Drug Administration
  • the invention concerns thermoplastic elastomers as described above, for implants in and near bone, especially those which are surrounded by bone over time, and until then may substitute bone.
  • the bone implant will perform a spacing function and/or will serve to hold existing bone in place and/or maintain alignment of bone, and thus bear load.
  • the foregoing expressly, and preferably, includes the situation where the bones held in place and/or aligned are joints.
  • These include implants for 1.) facial bones used to augment, reconstruct, correct aesthetic defects (e.g. chin, cheeks, jaw, etc.), 2.) dental applications (to the extent applicable to bone), to retain or maintain the shape of the jaw, 3.) spinal fusion implants, including spinal fusion cages, intervertebral bodies, etc.
  • the implants can be made from the TPE material by any known method to shape such TPEs.
  • Known techniques include (co-)injection moulding, (co-)extrusion moulding, blow moulding or injection overmoulding.
  • the TPE's according to the invention can be applied in multi component molding, for example, two component (2K) molding, either with other
  • Multi component molding makes it possible to produce designs comprising hard and soft parts, or parts with different properties.
  • Arnitel ® grades are particularly suitable because of their superior adhesion to other types of Arnitel ® , other polymers and metal. Good adhesion prevents separation of the implant parts, which may lead to a number of complications including implant migration, blood vessel and/or nerve damage from the migrated implant, etc.
  • multi component molding enables a number of innovative design features. For instance, overmoulding softer TPE grades at specific points in an implant: 1.) enable designs with built-in failure points, e.g. at the points where the softer material has been overmoulded.
  • This provides a predictable failure mode for the implant and a predictable point of failure, which, for example may be intentionally provided to allow the implant to fail in a "safe" mode upon exposure to abnormal or excessive forces and/or to absorb the some of the impact of these forces.
  • 2.) enable designs where implants can be provided in a compact form for minimally invasive surgery where the implant is unfolded and/or expanded after or during implantation.
  • the TPE of the invention can be used as such, or in a modified form, or combined with other materials. This depends on the key properties desired.
  • a TPE as defined above can be applied in high load-bearing applications, such as long bone trauma.
  • the key properties are modulus, tension set, tensile creep, crack, tear, and abrasion resistance. Although these properties can be well provided for by the aforementioned TPE's, it is preferred to use the TPE overmould on titanium, stainless steel, or performance plastic.
  • TPE polystyrene-co-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrenethacrylate terephthalate terephthalate-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-styrene-st
  • TPE in compressive load-bearing implants.
  • the key properties are compression set, compressive creep, and crack resistance, and in this respect the benefits of the TPE's according to the invention can be enjoyed to the greatest extent.
  • a preferred modification of the TPE in these applications is to use TPE comprising a hard filler, so as to further increase stiffness.
  • the temperature and other processing conditions at which the TPE can best be processed depends on the melting temperature, the viscosity and other rheological properties of the TPE and can easily be determined by the person skilled in the art once said properties are known.
  • the above mentioned Arnitel ® grades have melting temperatures (measured according to ISO 11357-1/-3) between 180 and 221 0 C and are preferably processed at temperatures between 200 and 250 0 C.
  • the TPE's according to the invention can be sterilized by any known means.
  • the TPE's according to the invention can be foamed by any known method resulting in open or closed cell foam.
  • a hard TPE e.g. harder than Shore 8OA or 9OA
  • Shore 8OA or 9OA can be used to provide a foamed end product with good hydrolytic stability, wear and lipid resistance while still providing softer properties.
  • Alternatively a similar effect can be accomplished by applying specific designs, in particular open structures, like a spring-like structure.
  • 3-D selective laser sintering producing open structure implants of various porosity and open or closed cell structure can be used to modify the surface texture and properties, e.g. hydrophilicity.
  • Fused deposition modelling as described in for example
  • Biomaterials, 2004 Aug: 25 (18), pp. 4149-4161 can also be used to produce open structures with varying degrees of void volume and mechanical properties. In addition, these have been demonstrated to be effective in culturing cells and tissues.
  • Products for example those produced by 3-D selective laser sintering or fused deposition modelling, can be tailored for e.g. bone in-growth or bone fusion in a joint by adding osteoconductive filler, for example hydroxyapatite.
  • the TPE's according to the invention can be cut with a fluid jet for customizing the implant shape to the patient's anatomy.
  • a fluid jet for customizing the implant shape to the patient's anatomy.
  • Such fluid jets are described in patent US6960182 and are commercially provided by Hydrocision, Inc. (Billerica, MA).
  • Hydrocision, Inc. Hydrocision, Inc. (Billerica, MA).
  • the ability to customize an implant with a fluid jet represents a significant advance over the current standard of practice, where grinding tools (e.g. Dremel) are used to abrade the surfaces of implants, which result in damaged implant surfaces, possible introduction of wear particles in the operating room, etc.
  • Bone growth generally refers to any process in which two or more bones, bone fragments, or bone pieces are made to grow together, to rejoin, or to fuse.
  • Examples hereof include: joint fusion, i.e. when two bones grow together (fuse), such as vertebrae in spinal fusion; trauma, i.e. when two bone fragments or pieces grow together (such as the healing or rejoining of broken bones); reconstruction or correction of anatomical defects, i.e. two bone fragments or pieces created during surgery (e.g. by sawing) are joined.
  • TPE spacers are used between these fragments, and they grow back together.
  • TPE's as a bone implant in support of bone healing and particularly in joint fusion (arthrodesis).
  • Bone healing refers to, e.g., healing bone fractures, osteotomies, resections, dissections (either intentional, as in cosmetic/reconstructive surgery, or accidental as in trauma).
  • Arthrodesis refers to a surgical procedure, also known as joint fusion. The goal of arthrodesis is to provide pain relief, restore skeletal stability, and improve alignment in people with advanced arthritis. Not all arthritic joints are candidates for joint replacement surgery. Sometimes arthrodesis is the better surgical treatment option for those with arthritis. Arthrodesis is mostly performed on ankles and wrists but it can be performed on other joints.
  • Arthrodesis particularly is a good consideration for ankles, wrists, thumbs, toes, fingers, and vertebrae, particularly the cervical and lumbar vertebrae.
  • the ends of two bones are fused together in arthrodesis with screw fixation and possible bone grafting.
  • the bone implant is used preferably in the form of a cage/spacer/intervertebral body, but other forms are viable as well.
  • the invention further pertains to bone-growth procedures, such as procedures for bone healing and particularly for arthrodesis. These procedures by themselves are known to the skilled person, e.g. with reference to the aforementioned publications from the AO foundation.
  • the invention relates to the use of a thermoplastic elastomer in a load-bearing bone implant, suitable for permanent implantation, wherein the thermoplastic elastomer comprises a hard phase and soft phase, wherein the hard phase comprises a polymer chosen from the group consisting of polyester, polyamide, polystyrene, polyacrylate and polyolefin and the soft phase comprises a polymer chosen from the group consisting of polyether, polyester, polyacrylate, polyolefin and polysiloxane.
  • the thermoplastic elastomer can be in any of the embodiments described above with reference to implants.
  • thermoplastic elastomers used in the present invention can be manufactured in known manner, using regular polymeric synthesis methods.
  • Arnitel ® EL740 hard block polybutylene terepthalate (PBT), soft-block: polytetramethyleneoxide (PTMO), modulus 1 100 MPa) from DSM N.V.
  • Arnitel ® CM740 hard block: polybutylene terepthalate (PBT), soft-block: polyhexamethylenecarbonate, modulus 635 MPa
  • PBT polybutylene terepthalate
  • soft-block polyhexamethylenecarbonate, modulus 635 MPa
  • Arnitel ® EM400 hard block; polybutylene terepthalate (PBT), soft-block; polytetramethyleneoxide (PTMO), modulus 50 MPa
  • PBT polybutylene terepthalate
  • PTMO polytetramethyleneoxide
  • Arnitel ® EL250 hard block polybutylene terepthalate (PBT), soft-block: polytetramethyleneoxide (PTMO), modulus 25 MPa) from DSM N.V.
  • PBT PBT T06-200 , modulus 2700 MPa from DSM N.V.
  • PEEK in Example 3 Ketron ® PEEK-1000, modulus 4000 MPa from Eriks • Elastollan ® 119OA TPU; a polyether-urethane from BASF A.G.
  • Arnitel ® EL740 was used to produce a lumbar cage. Force requirements were compared to ISO draft standard ISO/DIS 18192-1 ; which includes peak axial loads of 2000N. The following table 2 summarizes strains and stress on the material given a variety of cage cross-sectional areas. These areas were also compared to the size of the average human endplate (1414 mm 2 - source: Journal of Biomechanics 36 (2003) 1875-1881 ).
  • the measured failure stress of human vertebral bone is between 6.3-7.2 MPa.
  • the implant made from Arnitel ® EL740 was thus more than capable of handling these load levels.
  • the strain levels were well within the elastic regime of the material, allowing for good creep performance over time.
  • the TPE used carried the required loads while only taking up a small fraction of total endplate area (thus not interfering with good bone regrowth/fusion).
  • the displacement and energy dissipated under a 2000N load (maximum ISO axial load) was estimated.
  • Energy was estimated as the area under the force/displacement curve and was calculated via numerical integration as show in Table 3 below for Arnitel ® EL740.
  • the implant height was 10mm (disc space), the area was 50 mm 2 .
  • the energy dissipated was 0.1 J.
  • the TPE used in accordance with the invention was capable of deforming to a much higher extent, and thus absorbed the impact energy rather than merely transmitting it (e.g. to the next vertebra) as PEEK does. In the latter case a higher stress on the next vertebra was produced, which increased the risk of fracturing the endplate.
  • the purpose of this example was to compare a spinal cage prepared from different materials.
  • Subsidence of the cage into the bone bed was determined according to ASTM 2267, using a polyurethane foam (grade 15, ASTM 1839) as a reproducible bone bed simulator. As incongruence between the implant and the bone bed appeared to be an important parameter for cage loading and subsidence, one foam bed was machined to have a curved surface with a radius of 28mm. The other foam bed remained flat.
  • the static strength of an open cage on the foam bed was determined for all three cage types. The foam appeared to fail at a load of some 450N. Subsequently, static loading at 70% of this static strength (i.e.: 300 N) was applied on the two polyurethane blocks and the cage in between for a period of ten minutes.
  • Expulsion testing was performed according to a test described by Goel et al., Summer Bioengineering Conference, Key Biscayne Florida, June 2003. The expulsion test was performed on cages clamped between two flat polyurethane foam blocks (grade 15, ASTM 1839) under a pre-stress of 300N and a constant speed of 0.4 mm/s. The sample number was three for all cage types.
  • TPE 2K and PEEK cages were all strong enough to be considered sufficient for in vivo loads in animals as well as humans (equivalent to approximately 10 times body weight).
  • the 2K cage showed further improvements in subsidence. Static and dynamic subsidence experiments showed that the 2K cages performed better in that respect as well: subsidence was more than 20% less as compared to the "hard" PEEK cages. The friction of the 2K cages resulted in the highest expulsion strength.
  • the 2K cage shows a remarkable behaviour with two ranges of stiffness; first a very low stiffness of both 1.0 kN/mm, followed by a stiffness comparable to the TPC cage (4.3 kN).
  • the stiffness of the TPE and 2K cages were an order of magnitude lower than of the PEEK cages; this should stimulate bone growth within the cage in an in vivo situation.
  • Cylindrical samples having a 13 mm diameter and 6 mm height were mounted between the plates of a MTS 810-11 servo-hydraulic tensile tester.
  • the samples were loaded force controlled by a harmonically time varying compressive force.
  • the cycle frequency of the force signal was 0.25 Hz.
  • the maximum compressive stress during a cycle was 4 MPa whereas the minimum compressive stress was 0.4 MPa.
  • the experiments were carried out in an oven at 37°C.
  • the stress levels that were applied were derived from ASTM 2423-05, and were chosen to be higher by a factor 4.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

L’invention concerne un implant osseux porteur de charge d’un type adapté en vue d’une implantation permanente. Cet implant est constitué d’un élastomère thermoplastique comportant une phase dure et une phase molle, ladite phase dure comportant un polymère choisi dans le groupe constitué par un polyester, un polyamide, un polystyrène, un polyacrylate et une polyoléfine et ladite phase molle comportant un polymère choisi dans le groupe constitué par un polyéther, un polyester, un polyacrylate, une polyoléfine et un polysiloxane.
PCT/EP2009/052643 2008-03-05 2009-03-05 Implant osseux porteur de charge comportant un élastomère thermoplastique WO2009109645A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN2010800106379A CN102341131A (zh) 2009-03-05 2010-03-05 脊柱融合器
JP2011552468A JP2012519516A (ja) 2009-03-05 2010-03-05 脊椎固定ケージ
PCT/EP2010/052854 WO2010100267A1 (fr) 2009-03-05 2010-03-05 Cage pour spondylodèse
US13/203,131 US9452061B2 (en) 2009-03-05 2010-03-05 Spinal fusion cage
EP10706668A EP2403548A1 (fr) 2009-03-05 2010-03-05 Cage pour spondylodèse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6442608P 2008-03-05 2008-03-05
US61/064,426 2008-03-05

Publications (2)

Publication Number Publication Date
WO2009109645A2 true WO2009109645A2 (fr) 2009-09-11
WO2009109645A3 WO2009109645A3 (fr) 2010-01-07

Family

ID=40651293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/052643 WO2009109645A2 (fr) 2008-03-05 2009-03-05 Implant osseux porteur de charge comportant un élastomère thermoplastique

Country Status (1)

Country Link
WO (1) WO2009109645A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100267A1 (fr) * 2009-03-05 2010-09-10 Dsm Ip Assets B.V. Cage pour spondylodèse

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891783A1 (fr) * 1997-07-16 1999-01-20 Isotis B.V. Dispositif pour la régénération osseuse consistant d'un copolyester thermoplastique biodégradable et de cellules cultivées
US20070014848A1 (en) * 2005-07-15 2007-01-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Resorbable Polyetheresters and Medicinal Implants Made Therefrom

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891783A1 (fr) * 1997-07-16 1999-01-20 Isotis B.V. Dispositif pour la régénération osseuse consistant d'un copolyester thermoplastique biodégradable et de cellules cultivées
US20070014848A1 (en) * 2005-07-15 2007-01-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Resorbable Polyetheresters and Medicinal Implants Made Therefrom

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EL FRAY M ET AL: "Preparation and bioactivity of novel multiblock thermoplastic elastomer/tricalcium phosphate composites" JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE, KLUWER ACADEMIC PUBLISHERS, BO, vol. 18, no. 3, 1 March 2007 (2007-03-01), pages 501-506, XP019481282 ISSN: 1573-4838 *
PROWANS P ET AL: "Biocompatibility studies of new multiblock poly(ester-ester)s composed of poly(butylene terephthalate) and dimerized fatty acid" BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 23, no. 14, 1 July 2002 (2002-07-01), pages 2973-2978, XP004353896 ISSN: 0142-9612 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100267A1 (fr) * 2009-03-05 2010-09-10 Dsm Ip Assets B.V. Cage pour spondylodèse

Also Published As

Publication number Publication date
WO2009109645A3 (fr) 2010-01-07

Similar Documents

Publication Publication Date Title
Patel et al. A review on biomaterials: scope, applications & human anatomy significance
Aherwar et al. Current and future biocompatibility aspects of biomaterials for hip prosthesis.
Ramakrishna et al. Biomedical applications of polymer-composite materials: a review
US8353964B2 (en) Anatomic total disc replacement
Mahyudin et al. Biomaterials in orthopaedics
JP4173009B2 (ja) 球形脊椎インプラント
US20200282105A1 (en) Spinal implants with bioactive glass markers
JP2010510026A (ja) 最小侵襲性のモジュール式椎体間固定器具に関する方法および装置
Lakes Composite biomaterials
EP2757999A1 (fr) Implant de tissu dur
US20100324689A1 (en) Implant comprising thermoplastic elastomer
US20120046750A1 (en) Spinal fusion cage
Katti et al. Materials for joint replacement
US10617788B2 (en) Collagen permeated medical implants
Vuono‐Hawkins et al. Materials and design concepts for an intervertebral disc spacer. II. Multidurometer composite design
Sacks et al. Polyaryletherketones: Properties and applications in modern medicine
Gloria et al. Composite materials for spinal implants
WO2009109645A2 (fr) Implant osseux porteur de charge comportant un élastomère thermoplastique
EP2533725A1 (fr) Implant orthopédique
WO2021239932A1 (fr) Implant médical pour le remplacement de cartilage et procédé de fabrication d'un tel implant
WO2009063025A2 (fr) Implant comportant un élastomère thermoplastique
Park et al. Hard tissue replacement—II: Joints and teeth
Zhao Bioactive materials in orthopaedics
Baran et al. Biomaterials Applications in Medicine and Case Studies
Macheras et al. Cementless fully porous-coated implant-bone interface in revision total hip arthroplasty

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09717096

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09717096

Country of ref document: EP

Kind code of ref document: A2